Metabolism of Polychlorinated Dibenzo-p-dioxins (PCDDs) by Human Cytochrome P450-Dependent Monooxygenase Systems
- 8 August 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 50 (19) , 5496-5502
- https://doi.org/10.1021/jf020415z
Abstract
Metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) by monooxygenase systems dependent on 12 forms of human cytochrome P450 (CYP) was examined with the recombinant yeast microsomes containing each of the human CYP. The metabolites of PCDDs were analyzed by HPLC and GC-MS. Remarkable metabolism by the multiple CYP forms was observed toward dibenzo-p-dioxin (DD) and mono-, di-, and trichloroDDs. The metabolism contained multiple reactions such as hydroxylation at an unsubstituted position, hydroxylation with migration of a chloride substituent, and hydroxylation with elimination of a chloride substituent. Although major CYPs in human liver such as CYP2C8, CYP2C9, and CYP3A4 showed no significant metabolism toward the PCDDs, CYP1A1 and CYP1A2 showed high catalytic activity toward DD and mono-, di-, and trichloroDDs. The kinetic parameters Kmapp and Vmax of the CYP1A1-dependent 8-hydroxylation activity of 2,3,7-trichloro-DD (2,3,7-triCDD) were estimated to be 0.30 μM and 51 (mol/min/mol of P450), respectively, suggesting that 2,3,7-triCDD was a good substrate for CYP1A1. However, none of the CYPs showed any detectable activity [<0.01 mol/min/mol of P450)] toward 2,3,7,8-tetraCDD. Substrate-induced absorption spectrum and inhibition studies indicated that CYP1A1 could bind 2,3,7,8-tetraCDD with considerably high affinity. It was strongly suggested that the long half-life (7.1 years) of 2,3,7,8-tetraCDD in humans was due to an extremely low activity of CYPs toward 2,3,7,8-tetraCDD in addition to its chemical stability. Keywords: Dioxin; PCDD; cytochrome P450; CYP; recombinant yeastKeywords
This publication has 20 references indexed in Scilit:
- Coexpression of Genetically Engineered Fused Enzyme between Yeast NADPH–P450 Reductase and Human Cytochrome P450 3A4 and Human Cytochrome b5 in YeastArchives of Biochemistry and Biophysics, 2000
- Practical application of mammalian cytochrome P450Journal of Bioscience and Bioengineering, 2000
- Inhibitory Effects of Vitamin A and Vitamin K on Rat Cytochrome P4501A1-Dependent Monooxygenase ActivityBiochemical and Biophysical Research Communications, 1999
- Multiple forms of human P450 expressed in Saccharomyces cerevisiaeBiochemical Pharmacology, 1996
- The Toxicokinetics and Metabolism of Polychlorinated Dibenzo-p-Dioxins (PCDDs) and Dibenzofurans (PCDFs) and Their Relevance for ToxicityCritical Reviews in Toxicology, 1994
- Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxinArchives of Toxicology, 1988
- Pharmacokinetics of 2,3,7,8-TCDD in manChemosphere, 1986
- Expression of Rat Liver Cytochrome P-450MC cDNA inSaccharomyces cerevisiaeDNA, 1985
- Structure elecidation of mammalian TCDD-metabolitesCellular and Molecular Life Sciences, 1982
- Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in ratsToxicology and Applied Pharmacology, 1978